Their main rival, sibutramine (Reductil), claims similar benefits in clinical trials but, once again, real-world results tend to be disappointing.
英
美
- 他们的主要竞争对手,西布曲明(诺美亭),声称在试点诊所也有相似的疗效,但是事实却再一次让人们失望。